These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10212182)

  • 1. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1.
    Urano T; Yashiroda H; Muraoka M; Tanaka K; Hosoi T; Inoue S; Ouchi Y; Toyoshima H
    J Biol Chem; 1999 Apr; 274(18):12197-200. PubMed ID: 10212182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells.
    Nishimori S; Tanaka Y; Chiba T; Fujii M; Imamura T; Miyazono K; Ogasawara T; Kawaguchi H; Igarashi T; Fujita T; Tanaka K; Toyoshima H
    J Biol Chem; 2001 Apr; 276(14):10700-5. PubMed ID: 11152674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation.
    Kim M; Nakamoto T; Nishimori S; Tanaka K; Chiba T
    EMBO Rep; 2008 Sep; 9(9):878-84. PubMed ID: 18660753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.
    Tadlock L; Yamagiwa Y; Hawker J; Marienfeld C; Patel T
    Am J Physiol Cell Physiol; 2003 Aug; 285(2):C277-85. PubMed ID: 12646415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.
    Leibovitch MP; Kannengiesser C; Leibovitch SA
    FEBS Lett; 2003 May; 543(1-3):125-8. PubMed ID: 12753918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of the p57(Kip2) gene in bone metabolism.
    Urano T; Hosoi T; Shiraki M; Toyoshima H; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2000 Mar; 269(2):422-6. PubMed ID: 10708569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
    Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
    Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation.
    Stewart MC; Kadlcek RM; Robbins PD; MacLeod JN; Ballock RT
    J Bone Miner Res; 2004 Jan; 19(1):123-32. PubMed ID: 14753744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14.
    Hsu S; Yamamoto T; Borke J; Walsh DS; Singh B; Rao S; Takaaki K; Nah-Do N; Lapp C; Lapp D; Foster E; Bollag WB; Lewis J; Wataha J; Osaki T; Schuster G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):884-90. PubMed ID: 15537824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina.
    Dyer MA; Cepko CL
    Development; 2000 Aug; 127(16):3593-605. PubMed ID: 10903183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
    Zhang F; Mönkkönen M; Roth S; Laiho M
    Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1.
    Hashimoto O; Ueno T; Kimura R; Ohtsubo M; Nakamura T; Koga H; Torimura T; Uchida S; Yamashita K; Sata M
    Mol Carcinog; 2003 Apr; 36(4):171-82. PubMed ID: 12669309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
    Li G; Domenico J; Lucas JJ; Gelfand EW
    J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes.
    Gosselet FP; Magnaldo T; Culerrier RM; Sarasin A; Ehrhart JC
    Cell Signal; 2007 Apr; 19(4):731-9. PubMed ID: 17112701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif.
    Spencer ML; Theodosiou M; Noonan DJ
    J Biol Chem; 2004 Aug; 279(35):37069-78. PubMed ID: 15229225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of components of the ubiquitin-proteasome pathway during lens cell differentiation.
    Guo W; Shang F; Liu Q; Urim L; West-Mays J; Taylor A
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1194-201. PubMed ID: 15037588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase inhibitor p57(Kip2) mediates proliferative actions of PTHrP in chondrocytes.
    MacLean HE; Guo J; Knight MC; Zhang P; Cobrinik D; Kronenberg HM
    J Clin Invest; 2004 May; 113(9):1334-43. PubMed ID: 15124025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.